Chair

Chair

Ivania Maritza Rizo, MD

BOSTON MEDICAL CENTER

Chair

Samar Hafida, MD

VP Obesity Association/ ADA Boston University/ Boston Medical Center

Potential Glucose-Lowering Properties of Paxlovid® in Type 2 Diabetes Patients

Sarah Dickerman, MS

University of Connecticut School of Medicine

Assessing Provider Perspectives in Delivering Diabetes Self Management (DSMES) and Transfer of Care in Emerging Adults (EAs) with Type 1 Diabetes (T1D): A Human Centered Design Approach

Jason M Ng, MD

University of Pittsburgh

Evaluating the Clinical Use of Verapamil in Type 1 Diabetes: A Real-World Experience

Tugce Akcan

STANFORD UNIVERSITY

Early Insulin Degludec With Continuous Intravenous Insulin Infusion in the Management of Diabetic Ketoacidosis: A Randomized Controlled Trial

Kitti Thammakosol, MD

Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University

Real-World Evidence on GLP-1 Analogues: Insights into NAION Risk in Type 2 Diabetes Mellitus Patients

Maxim John Levy Barnett, MBChB, MSc, MSc, PGD

Jefferson-Einstein Hospital

Efficacy and Safety of the SGLT1 Inhibitor Mizagliflozin in Patients with Post-Bariatric Hypoglycemia

Helen Margaret Lawler, MD

University of Colorado School of Medicine

Nesidioblastosis in Patients With Severe Post-bariatric Hypoglycemia: A Monocentric Case Series

Danielle Kirelik Dawes, MD

University of Colorado